1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Amgen Inc (AMGN)

  7. Amgen Inc (AMGN) Financials

AMGN

Amgen Inc
238.49
5.39 (2.31%)
Upgrade to Real-Time

Amgen Inc. (AMGN) Fundamentals
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
SHARE INFORMATION
Market CapUS$ 122,723,758,780
Shares Outstanding533,976,238
Float533,400,542
Percent Float99.89%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 7.76
Latest Fiscal RevenueUS$ 26,323,000,000
Latest Fiscal EPSUS$ 12.11
Latest Fiscal Date2022-12-31
DIVIDENDS
Dividend (3 Years)US$ 10.17
Dividend (5 Years)US$ 10.76
Ex Dividend Date2023-05-17
Dividend RateUS$ 8.52
Dividend Yield3.71%
Payment CashCash
HOLDERS
Institutions3,884
Institutional Holdings Date2023-02-28
Institutional Bought Previous 3 Months32,299,106
Institutional Holdings Percent138.0%
Institutional Sold Previous 3 Months46,027,191
Insider Holdings Date2023-02-28
Insider Bought Previous 3 Months-
Insider Holdings Percent0.6
Insider Sold Previous 3 Months-
Insider Shares Owned3,221,417
TRADING INFO
52 Week HighUS$ 296.67
52 Week LowUS$ 223.30
52 Week High ChangeUS$ 0.2862
21 Day Moving AverageUS$ 232.6538
21 Day Extended Moving AverageUS$ 234.0711
50 Day Moving AverageUS$ 243.1357
50 Day Extended Moving AverageUS$ 242.2085
200 Day Moving AverageUS$ 248.0824
200 Day Extended Moving AverageUS$ 249.1448
10 Day Average Volume2,982,017
20 Day Average Volume2,572,676
30 Day Average Volume2,568,742
50 Day Average Volume2,550,680
Alpha0.003617
Beta0.6461
Standard Deviation0.070822
R20.241348
7 Day Price ChangeUS$ -5.07
7 Day Percent Change-2.16%
21 Day Price ChangeUS$ -6.36
21 Day Percent Change-2.69%
30 Day Price ChangeUS$ -6.33
30 Day Percent Change-2.68%
Month to Date Price ChangeUS$ -1.83
Month to Date Percent Change-0.79%
Quarter to Date Price ChangeUS$ -30.51
Quarter to Date Percent Change-11.72%
180 Day Price ChangeUS$ 5.62
180 Day Percent Change2.5%
200 Day Price ChangeUS$ -8.78
200 Day Percent Change-3.68%
Year to Date Price ChangeUS$ -30.51
Year to Date Percent Change-11.72%

Amgen Inc. (AMGN) Key Ratios

PROFITABILITY
EBIT Margin34.4%
EBITDA Margin47.1%
Pre-Tax Profit Margin33.3%
Profit Margin Count25.02%
Gross Margin74.2%
Profit Margin TOT25.02%
INCOME STATEMENTS
RevenueUS$ 26,323,000,000
Revenue Per ShareUS$ 49.2962
Revenue (3 Years)US$ 3.87
Revenue (5 Years)US$ 3.08
FINANCIAL STRENGTH
Price to Tangible Book-4.50
Total Debt To Equity10.60
Int Coverage6.20
Current Ratio1.40
Leverage Ratio22.90
Quick Ratio1.00
Long Term Debt To Capital0.91
VALUATION MEASURES
PE Ratio19.20
Enterprise ValueUS$ 154,029,764,642
Price to Sales4.6622
Price to Free Cash144.30
PE High Last 5 Years78.10
Price To Book34.00
Price To Cash Flow13.00
PE Low Last 5 Years13.20
Price to Tangible Book-4.50
MANAGEMENT EFFECTIVENESS
Receivables Turnover4.20
Invoice Turnover1.50
Assets Turnover0.40
Return Assets10.67
Return on Equity131.29
Return on Capital18.17

Amgen Inc. (AMGN) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEORobert A. Bradway
Emplyoees25200
Last AuditUQ
CIK0000318154
IndustryDrug Manufacturers
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
AddressOne Amgen Center Drive
Thousand Oaks, CA 91320-1799
Websitehttps://www.amgen.com
Facsimile+1 805 447-1010
Telephone+1 805 447-1000
Emailinvestor.relations@amgen.com
Your Recent History
NASDAQ
AMGN
Amgen
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20230325 10:52:06